Free Trial

Victory Capital Management Inc. Acquires 41,449 Shares of Innospec Inc. (NASDAQ:IOSP)

Innospec logo with Basic Materials background

Victory Capital Management Inc. grew its holdings in Innospec Inc. (NASDAQ:IOSP - Free Report) by 4.8% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 908,032 shares of the specialty chemicals company's stock after purchasing an additional 41,449 shares during the quarter. Victory Capital Management Inc. owned about 3.64% of Innospec worth $102,689,000 as of its most recent filing with the SEC.

Other institutional investors have also made changes to their positions in the company. DekaBank Deutsche Girozentrale acquired a new position in shares of Innospec during the 1st quarter worth about $66,000. CWM LLC increased its stake in Innospec by 239.6% in the second quarter. CWM LLC now owns 635 shares of the specialty chemicals company's stock valued at $78,000 after purchasing an additional 448 shares in the last quarter. Blue Trust Inc. boosted its position in shares of Innospec by 503.9% during the third quarter. Blue Trust Inc. now owns 779 shares of the specialty chemicals company's stock worth $96,000 after purchasing an additional 650 shares in the last quarter. nVerses Capital LLC grew its holdings in shares of Innospec by 200.0% in the 3rd quarter. nVerses Capital LLC now owns 900 shares of the specialty chemicals company's stock valued at $102,000 after buying an additional 600 shares during the period. Finally, Motco bought a new stake in shares of Innospec in the 1st quarter valued at $132,000. 96.64% of the stock is owned by institutional investors.

Innospec Price Performance

IOSP stock traded up $0.07 during midday trading on Thursday, hitting $121.85. The company's stock had a trading volume of 107,168 shares, compared to its average volume of 108,993. Innospec Inc. has a twelve month low of $103.97 and a twelve month high of $133.71. The stock has a market capitalization of $3.04 billion, a P/E ratio of 21.27 and a beta of 1.08. The company's fifty day moving average price is $112.24 and its 200 day moving average price is $118.84.

Innospec (NASDAQ:IOSP - Get Free Report) last released its quarterly earnings data on Tuesday, November 5th. The specialty chemicals company reported $1.35 EPS for the quarter, hitting analysts' consensus estimates of $1.35. The firm had revenue of $443.40 million during the quarter, compared to analysts' expectations of $442.13 million. Innospec had a net margin of 7.68% and a return on equity of 13.33%. The company's revenue for the quarter was down 4.5% compared to the same quarter last year. During the same period in the previous year, the business posted $1.59 earnings per share. Equities analysts expect that Innospec Inc. will post 5.88 EPS for the current fiscal year.

Innospec Increases Dividend

The business also recently disclosed a Semi-Annual dividend, which will be paid on Tuesday, November 26th. Shareholders of record on Monday, November 18th will be given a dividend of $0.79 per share. The ex-dividend date of this dividend is Monday, November 18th. This is an increase from Innospec's previous Semi-Annual dividend of $0.72. This represents a yield of 1.3%. Innospec's dividend payout ratio (DPR) is 26.53%.

Insider Activity

In other Innospec news, CFO Ian Cleminson sold 3,398 shares of the firm's stock in a transaction on Monday, August 26th. The stock was sold at an average price of $114.74, for a total transaction of $389,886.52. Following the transaction, the chief financial officer now owns 12,996 shares in the company, valued at $1,491,161.04. This trade represents a 20.73 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 1.52% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

Separately, StockNews.com cut Innospec from a "strong-buy" rating to a "buy" rating in a research note on Thursday, August 8th.

Get Our Latest Stock Analysis on Innospec

Innospec Profile

(Free Report)

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.

Recommended Stories

Institutional Ownership by Quarter for Innospec (NASDAQ:IOSP)

Should you invest $1,000 in Innospec right now?

Before you consider Innospec, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Innospec wasn't on the list.

While Innospec currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Why Whitestone REIT is Outperforming in 2024: 35% Growth & Monthly Dividends
Why SoundHound Stock Dip Could Mean Big Gains for 2025 Investors
Nintendo Stock: Buy Before the 2025 Switch Platform Hits!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines